PDL BioPharma ROA 2006-2020 | PDLI

Current and historical return on assets (ROA) values for PDL BioPharma (PDLI) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
PDL BioPharma ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2020-06-30 $-0.16B $0.52B -22.44%
2020-03-31 $-0.11B $0.66B -13.92%
2019-12-31 $-0.07B $0.72B -8.24%
2019-09-30 $0.00B $0.87B 0.11%
2019-06-30 $0.05B $0.89B 4.78%
2019-03-31 $-0.06B $0.92B -6.60%
2018-12-31 $-0.07B $0.96B -6.81%
2018-09-30 $-0.06B $0.98B -5.80%
2018-06-30 $-0.07B $0.95B -5.94%
2018-03-31 $0.11B $1.10B 8.63%
2017-12-31 $0.11B $1.24B 8.79%
2017-09-30 $0.08B $1.22B 6.27%
2017-06-30 $0.07B $1.30B 5.71%
2017-03-31 $0.02B $1.24B 1.27%
2016-12-31 $0.06B $1.22B 5.64%
2016-09-30 $0.18B $1.22B 16.16%
2016-06-30 $0.23B $1.05B 22.24%
2016-03-31 $0.30B $1.06B 29.77%
2015-12-31 $0.33B $1.01B 32.05%
2015-09-30 $0.29B $1.02B 27.95%
2015-06-30 $0.32B $1.00B 31.49%
2015-03-31 $0.33B $1.11B 33.53%
2014-12-31 $0.32B $0.96B 34.71%
2014-09-30 $0.33B $0.98B 39.84%
2014-06-30 $0.28B $0.92B 41.12%
2014-03-31 $0.28B $0.85B 50.99%
2013-12-31 $0.26B $0.54B 62.56%
2013-09-30 $0.25B $0.43B 70.79%
2013-06-30 $0.25B $0.40B 78.78%
2013-03-31 $0.23B $0.31B 81.60%
2012-12-31 $0.21B $0.28B 82.73%
2012-09-30 $0.20B $0.25B 79.68%
2012-06-30 $0.20B $0.26B 76.91%
2012-03-31 $0.20B $0.24B 73.65%
2011-12-31 $0.20B $0.27B 74.56%
2011-09-30 $0.14B $0.27B 48.88%
2011-06-30 $0.13B $0.28B 47.29%
2011-03-31 $0.11B $0.25B 40.51%
2010-12-31 $0.09B $0.32B 30.54%
2010-09-30 $0.15B $0.26B 47.31%
2010-06-30 $0.15B $0.27B 49.03%
2010-03-31 $0.18B $0.36B 60.44%
2009-12-31 $0.19B $0.34B 72.76%
2009-09-30 $0.20B $0.26B 90.13%
2009-06-30 $0.21B $0.22B 62.70%
2009-03-31 $0.17B $0.22B 37.71%
2008-12-31 $0.07B $0.19B 10.29%
2008-09-30 $0.01B $0.72B 1.30%
2008-06-30 $-0.05B $0.65B -4.85%
2008-03-31 $-0.07B $1.12B -6.27%
2007-12-31 $-0.02B $1.19B -1.89%
2007-09-30 $-0.10B $1.16B -8.33%
2007-06-30 $-0.10B $1.18B -8.35%
2007-03-31 $-0.12B $1.12B -9.91%
2006-12-31 $-0.13B $1.14B -11.08%
2006-09-30 $-0.07B $1.20B -6.28%
2006-06-30 $-0.11B $1.18B -9.55%
2006-03-31 $-0.11B $1.17B -9.46%
2005-12-31 $-0.17B $1.16B -14.94%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.282B $0.055B
Protein Design Labs Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a leader in the development of humanized antibodies, PDL has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.950B 9.21
Amgen (AMGN) United States $128.168B 13.37
CSL (CSLLY) Australia $89.421B 0.00
Gilead Sciences (GILD) United States $79.454B 8.92
Illumina (ILMN) United States $58.303B 88.80
Vertex Pharmaceuticals (VRTX) United States $54.017B 22.96
Moderna (MRNA) United States $52.890B 0.00
Regeneron Pharmaceuticals (REGN) United States $48.143B 15.73
Biogen (BIIB) United States $40.151B 8.03
Alexion Pharmaceuticals (ALXN) United States $32.639B 12.71
BeiGene (BGNE) Cayman Islands $26.456B 0.00
Seagen (SGEN) United States $26.350B 45.17
BioNTech SE (BNTX) Germany $22.911B 0.00
Exact Sciences (EXAS) United States $20.464B 0.00
Genmab (GMAB) Denmark $20.267B 28.37
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.827B 0.00
Horizon Therapeutics Public (HZNP) Ireland $19.311B 22.16
Genmab (GNMSF) Denmark $18.450B 4.37
Bio-Rad Laboratories (BIO.B) United States $17.927B 57.05
Incyte (INCY) United States $17.038B 0.00
Alnylam Pharmaceuticals (ALNY) United States $16.073B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.883B 110.65
ARGENX SE-ADR (ARGX) Netherlands $13.790B 0.00
Bio-Techne Corp (TECH) United States $13.498B 77.31
Guardant Health (GH) United States $13.372B 0.00
Zai Lab (ZLAB) China $11.713B 0.00
Novavax (NVAX) United States $11.677B 0.00
QIAGEN (QGEN) Netherlands $10.836B 22.13
Repligen (RGEN) United States $10.035B 110.37
Mirati Therapeutics (MRTX) United States $9.165B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $8.711B 0.00
Ultragenyx Pharmaceutical (RARE) United States $7.942B 0.00
Fate Therapeutics (FATE) United States $7.797B 0.00
Acceleron Pharma (XLRN) United States $7.744B 0.00
Ascendis Pharma (ASND) Denmark $7.663B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.333B 0.00
Denali Therapeutics (DNLI) United States $7.102B 225.77
Exelixis (EXEL) United States $6.649B 60.89
Sarepta Therapeutics (SRPT) United States $6.525B 0.00
Adaptive Biotechnologies (ADPT) United States $6.081B 0.00
Twist Bioscience (TWST) United States $5.673B 0.00
Galapagos (GLPG) Belgium $5.552B 0.00
Halozyme Therapeutics (HALO) United States $5.467B 44.90
Blueprint Medicines (BPMC) United States $5.333B 17.56
NeoGenomics (NEO) United States $5.285B 645.57
Vir Biotechnology (VIR) United States $5.071B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $4.890B 15.38
Emergent Biosolutions (EBS) United States $4.843B 11.58
Biohaven Pharmaceutical Holding (BHVN) United States $4.821B 0.00
Certara (CERT) United States $4.669B 0.00
China Biologic Products (CBPO) China $4.647B 30.12
Arena Pharmaceuticals (ARNA) United States $4.315B 0.00
Reata Pharmaceuticals (RETA) United States $4.263B 0.00
Beam Therapeutics (BEAM) United States $4.260B 0.00
I-Mab (IMAB) China $3.997B 0.00
Insmed (INSM) United States $3.842B 0.00
Intellia Therapeutics (NTLA) United States $3.686B 0.00
Apellis Pharmaceuticals (APLS) United States $3.669B 0.00
Arvinas (ARVN) United States $3.474B 0.00
Berkeley Lights (BLI) United States $3.458B 0.00
SpringWorks Therapeutics (SWTX) United States $3.394B 0.00
MorphoSys AG (MOR) Germany $3.171B 114.76
Legend Biotech (LEGN) United States $3.109B 0.00
Viela Bio (VIE) United States $2.910B 0.00
Alkermes (ALKS) Ireland $2.900B 0.00
NantKwest (NK) United States $2.807B 0.00
Amicus Therapeutics (FOLD) United States $2.736B 0.00
Editas Medicine (EDIT) United States $2.719B 0.00
Intra-Cellular Therapies (ITCI) United States $2.692B 0.00
Global Blood Therapeutics (GBT) United States $2.507B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.476B 0.00
Sorrento Therapeutics (SRNE) United States $2.474B 0.00
Arcus Biosciences (RCUS) United States $2.367B 0.00
Ligand Pharmaceuticals (LGND) United States $2.354B 44.56
Morphic Holding (MORF) United States $2.242B 0.00
Amarin (AMRN) Ireland $2.224B 0.00
PHARMA MAR SA (PHMMF) Spain $2.211B 0.00
Myriad Genetics (MYGN) United States $2.138B 0.00
Dicerna Pharmaceuticals (DRNA) United States $2.065B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.987B 16.45
Genetron Holdings (GTH) China $1.916B 0.00
Inovio Pharmaceuticals (INO) United States $1.900B 0.00
Bluebird Bio (BLUE) United States $1.876B 0.00
NGM Biopharmaceuticals (NGM) United States $1.864B 0.00
Vericel (VCEL) United States $1.857B 808.20
Revance Therapeutics (RVNC) United States $1.835B 0.00
Pandion Therapeutics (PAND) United States $1.815B 0.00
Scholar Rock Holding (SRRK) United States $1.702B 0.00
Precigen (PGEN) United States $1.684B 0.00
REGENXBIO (RGNX) United States $1.666B 0.00
Seres Therapeutics (MCRB) United States $1.653B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.637B 0.00
Sangamo Therapeutics (SGMO) United States $1.609B 0.00
Travere Therapeutics (TVTX) United States $1.587B 0.00
Heska (HSKA) United States $1.582B 0.00
UniQure (QURE) Netherlands $1.483B 0.00
Zymeworks (ZYME) Canada $1.474B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.446B 0.00
Five Prime Therapeutics (FPRX) United States $1.445B 0.00
Frequency Therapeutics (FREQ) United States $1.406B 0.00
Castle Biosciences (CSTL) United States $1.376B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.376B 0.00
Zealand Pharma (ZEAL) Denmark $1.346B 0.00
Cytokinetics (CYTK) United States $1.321B 0.00
Alector (ALEC) United States $1.293B 0.00
Codexis (CDXS) United States $1.289B 0.00
Nurix Therapeutics (NRIX) United States $1.264B 0.00
Mersana Therapeutics (MRSN) United States $1.249B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $1.197B 0.00
Northwest Biotherapeutics (NWBO) United States $1.150B 0.00
Zealand Pharma (ZLDPF) Denmark $1.141B 0.00
Pliant Therapeutics (PLRX) United States $1.140B 0.00
MiMedx (MDXG) United States $1.118B 0.00
Coherus BioSciences (CHRS) United States $1.110B 9.02
Mesoblast (MESO) Australia $1.079B 0.00
Protagonist Therapeutics (PTGX) United States $1.075B 0.00
Adverum Biotechnologies (ADVM) United States $1.072B 0.00
Bionano Genomics (BNGO) United States $1.057B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.046B 0.00
Repare Therapeutics (RPTX) Canada $1.008B 0.00
Celldex Therapeutics (CLDX) United States $0.997B 0.00
Avid Bioservices (CDMO) United States $0.967B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.960B 40.67
Dynavax Technologies (DVAX) United States $0.959B 0.00
Epizyme (EPZM) United States $0.936B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.925B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.923B 0.00
Cara Therapeutics (CARA) United States $0.902B 226.00
G1 THERAPEUTICS (GTHX) United States $0.852B 0.00
Prothena (PRTA) Ireland $0.847B 0.00
Pharming Group (PHGUF) Netherlands $0.838B 22.32
Pharming Group (PHAR) $0.838B 0.00
MannKind (MNKD) United States $0.835B 0.00
Cellectis S.A (CLLS) France $0.820B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.807B 0.00
Kadmon Holdings (KDMN) United States $0.798B 0.00
Sutro Biopharma (STRO) United States $0.783B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.777B 0.00
AnaptysBio (ANAB) United States $0.770B 0.00
Cel-Sci (CVM) United States $0.743B 0.00
VBI Vaccines (VBIV) United States $0.721B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.708B 0.00
Merus (MRUS) Netherlands $0.680B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.667B 0.00
ALBIREO PHARMA (ALBO) United States $0.647B 0.00
Starpharma Holdings (SPHRY) Australia $0.644B 0.00
Sinovac Biotech (SVA) China $0.640B 35.94
Intercept Pharmaceuticals (ICPT) United States $0.638B 0.00
Agenus (AGEN) United States $0.601B 0.00
ChromaDex (CDXC) United States $0.592B 0.00
Clovis Oncology (CLVS) United States $0.592B 0.00
Precision BioSciences (DTIL) United States $0.578B 0.00
Compugen (CGEN) Israel $0.558B 0.00
DBV Technologies S.A (DBVT) France $0.551B 0.00
Geron (GERN) United States $0.550B 0.00
Anika Therapeutics (ANIK) United States $0.542B 181.57
Curis (CRIS) United States $0.537B 0.00
MeiraGTx Holdings (MGTX) United States $0.534B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.526B 0.00
AC Immune SA (ACIU) Switzerland $0.526B 0.00
Gritstone Oncology (GRTS) United States $0.513B 0.00
Amryt Pharma (AMYT) United Kingdom $0.499B 0.00
Neoleukin Therapeutics (NLTX) United States $0.479B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.477B 0.00
AMMO (POWW) United States $0.458B 0.00
WAVE Life Sciences (WVE) Singapore $0.456B 0.00
Affimed (AFMD) Germany $0.453B 0.00
Syros Pharmaceuticals (SYRS) United States $0.447B 0.00
Spero Therapeutics (SPRO) United States $0.438B 0.00
Kala Pharmaceuticals (KALA) United States $0.436B 0.00
Puma Biotechnology (PBYI) United States $0.431B 0.00
AquaBounty Technologies (AQB) United States $0.429B 0.00
Athenex (ATNX) United States $0.419B 0.00
Selecta Biosciences (SELB) United States $0.412B 0.00
Fulcrum Therapeutics (FULC) United States $0.408B 0.00
BioDelivery Sciences (BDSI) United States $0.406B 19.14
UROGEN PHARMA (URGN) United States $0.396B 0.00
Opthea (OPT) Australia $0.395B 0.00
XOMA (XOMA) United States $0.390B 0.00
Kaleido Biosciences (KLDO) $0.389B 0.00
Fortress Biotech (FBIO) United States $0.387B 0.00
Verastem (VSTM) United States $0.377B 0.00
Cue Biopharma (CUE) United States $0.371B 0.00
Athersys (ATHX) United States $0.364B 0.00
CytomX Therapeutics (CTMX) United States $0.351B 0.00
ANI Pharmaceuticals (ANIP) United States $0.351B 8.93
Aeglea BioTherapeutics (AGLE) United States $0.343B 0.00
Forte Biosciences (FBRX) United States $0.340B 0.00
Cardiff Oncology (CRDF) United States $0.340B 0.00
Innate Pharma S.A (IPHA) France $0.340B 0.00
Trevena (TRVN) United States $0.327B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.324B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.322B 0.00
Oncobiologics (OTLK) United States $0.314B 0.00
NextCure (NXTC) United States $0.314B 0.00
IBio (IBIO) United States $0.309B 0.00
Bellus Health (BLU) Canada $0.309B 0.00
Theratechnologies (THTX) Canada $0.294B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.279B 0.00
Kamada (KMDA) Israel $0.268B 15.44
Arbutus Biopharma (ABUS) United States $0.267B 0.00
Evofem Biosciences (EVFM) United States $0.266B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.264B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.262B 0.00
HOOKIPA Pharma (HOOK) United States $0.252B 0.00
Cerecor (CERC) United States $0.242B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.235B 0.00
TELA Bio (TELA) United States $0.229B 0.00
CorMedix Inc (CRMD) United States $0.228B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.225B 0.00
OSMOTICA PHARM (OSMT) United States $0.218B 0.00
Applied Genetic Technologies (AGTC) United States $0.216B 0.00
ADMA Biologics Inc (ADMA) United States $0.211B 0.00
Voyager Therapeutics (VYGR) United States $0.210B 5.87
INmune Bio (INMB) United States $0.207B 0.00
Abeona Therapeutics (ABEO) United States $0.205B 0.00
Aptinyx (APTX) United States $0.202B 0.00
Chiasma (CHMA) United States $0.199B 0.00
POXEL SA FRANCE (PXXLF) France $0.197B 0.00
Checkpoint Therapeutics (CKPT) United States $0.196B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.192B 0.00
GENFIT S.A (GNFT) France $0.189B 0.00
Strongbridge Biopharma (SBBP) United States $0.187B 0.00
Eton Pharmaceuticals (ETON) United States $0.187B 0.00
VolitionRX (VNRX) United States $0.182B 0.00
Exicure (XCUR) United States $0.181B 0.00
Idera Pharmaceuticals (IDRA) United States $0.179B 0.00
Nicox SA (NICXF) France $0.177B 0.00
Kindred Biosciences (KIN) United States $0.173B 0.00
Orgenesis (ORGS) United States $0.170B 352.00
Pluristem Therapeutics (PSTI) Israel $0.169B 0.00
VTv Therapeutics (VTVT) United States $0.167B 0.00
Antibe Therapeutics (ATBPF) Canada $0.166B 0.00
DiaMedica Therapeutics (DMAC) United States $0.162B 0.00
Palatin Technologies (PTN) United States $0.161B 0.00
Clearside Biomedical (CLSD) United States $0.157B 0.00
Protalix BioTherapeutics (PLX) Israel $0.151B 0.00
X4 Pharmaceuticals (XFOR) United States $0.150B 0.00
Cogent Biosciences (COGT) United States $0.145B 0.00
Aptevo Therapeutics (APVO) United States $0.144B 0.00
Seelos Therapeutics (SEEL) United States $0.142B 0.00
Biofrontera AG (BFRA) Germany $0.141B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.140B 0.00
Dyadic (DYAI) United States $0.136B 0.00
Enzo Biochem (ENZ) United States $0.132B 0.00
Aytu Bioscience (AYTU) United States $0.131B 0.00
Catalyst Biosciences (CBIO) United States $0.130B 0.00
Cyclerion Therapeutics (CYCN) United States $0.128B 0.00
TRACON Pharmaceuticals (TCON) United States $0.126B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.126B 0.00
Evogene (EVGN) Israel $0.122B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.120B 0.00
Liminal BioSciences (LMNL) Canada $0.118B 0.00
Prima BioMed (IMMP) Australia $0.118B 0.00
CytRx (CYTR) United States $0.116B 0.00
Liquidia Technologies (LQDA) United States $0.115B 0.00
Cidara Therapeutics (CDTX) United States $0.112B 0.00
Beyond Air (XAIR) United States $0.112B 0.00
Lumos Pharma (LUMO) United States $0.112B 0.00
Ecology Coatings (ABVC) United States $0.110B 0.00
Synlogic (SYBX) United States $0.108B 0.00
PHASEBIO PHARMA (PHAS) United States $0.107B 0.00
ARAVIVE, INC (ARAV) United States $0.105B 0.00
Celyad SA (CYAD) Belgium $0.103B 0.00
Cocrystal Pharma (COCP) United States $0.095B 0.00
Adocia (ADOCY) France $0.092B 0.00
Novogen (KZIA) Australia $0.089B 0.00
Vascular Biogenics (VBLT) Israel $0.086B 0.00
AIkido Pharma (AIKI) United States $0.083B 0.00
Stealth BioTherapeutics (MITO) United States $0.083B 37.25
Organovo Holdings (ONVO) United States $0.081B 0.00
Advaxis (ADXS) United States $0.079B 0.00
Cleveland BioLabs (CBLI) United States $0.079B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.073B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.070B 0.00
Emmaus Life Sciences (EMMA) United States $0.070B 0.00
AEterna Zentaris (AEZS) United States $0.070B 0.00
Celsion (CLSN) United States $0.069B 0.00
Windtree Therapeutics (WINT) United States $0.068B 0.00
Vaccinex (VCNX) United States $0.066B 0.00
AnPac Bio-Medical Science (ANPC) China $0.066B 0.00
Edesa Biotech (EDSA) Canada $0.066B 0.00
Purple Biotech (PPBT) Israel $0.064B 0.00
ZIVO Bioscience (ZIVO) United States $0.063B 0.00
Genetic Technologies (GENE) Australia $0.062B 0.00
ARIDIS PHARMACT (ARDS) United States $0.057B 0.00
Acorda Therapeutics (ACOR) United States $0.054B 0.96
Viracta Therapeutics (VIRX) United States $0.054B 0.00
Soligenix (SNGX) United States $0.054B 0.00
Happiness Biotech Group (HAPP) China $0.048B 0.00
Pulmatrix (PULM) United States $0.047B 0.00
ATyr Pharma (LIFE) United States $0.045B 0.00
Enveric Biosciences (ENVB) United States $0.045B 0.00
Yumanity Therapeutics (YMTX) United States $0.044B 0.00
BioCardia (BCDA) United States $0.043B 0.00
Alimera Sciences (ALIM) United States $0.039B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.036B 0.00
IMMURON (IMRN) Australia $0.033B 0.00
Prana Biotechnology (ATHE) Australia $0.032B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.030B 0.00
Lexaria Bioscience (LEXX) Canada $0.028B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.026B 0.00
Titan Pharmaceuticals (TTNP) United States $0.021B 0.00
Timber Pharmaceuticals (TMBR) United States $0.020B 0.00
Seneca Biopharma (SNCA) United States $0.019B 0.00
ThermoGenesis Holdings (THMO) United States $0.018B 0.00
GeoVax Labs (GOVX) United States $0.018B 0.00
Invo BioScience (INVO) United States $0.016B 0.00
Cyclo Therapeutics (CYTH) United States $0.013B 0.00
Benitec Biopharma (BNTC) United States $0.012B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Viridian Therapeutics (VRDN) United States $0.000B 0.00